Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

NCT02348203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

NIH

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: Aspirin
OTHER: Laboratory Biomarker Analysis
OTHER: Placebo Administration
OTHER: Placebo Administration
DRUG: Zileuton

Sponsor

National Cancer Institute (NCI)